Arum Therapeutics

Private

SeoulHealthcare & Life Scienceshttps://arumtherapeutics.com/

Last Round

Series A

Apr 19, 2021

Total Funding Raised

$8.79M

Company Overview

Arum Therapeutics is a biotechnology company that develops novel anticancer agents and therapeutics for rare diseases by utilizing a synthetic lethality platform targeting DNA damage response mechanisms.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

drug discoverysynthetic lethalitysmall-molecule drugsDNA damage responseDDRoncology therapeuticsbiotechdrug resistancerespiratory diseasein-silico drug discoverycomputational biologydrug licensingpharma R&Dprecision medicinetarget discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Arum Therapeutics Comparables

Compare Arum Therapeutics with similar companies based on industry and business-model similarity.

Arum Therapeutics comparables — related companies by embedding similarity
Company	Similarity	Market Cap
FoRx Therapeutics	82%
Nanyang Biologics	78%
Curovir AB	77%

View all Comparables

Arum Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Apr 19, 2021
Seed	Apr 1, 2020

View all Funding Rounds

Arum Therapeutics Investors

Notable investors and investment history

Arum Therapeutics investors
Investor	Rounds
KDB Capital Corp	Series A
DAYLI Partners	Seed, Series A
SBI Investment Korea	Series A
Partners Investment	Series A
AJU IB Investment	Series A

View all Investors

Arum Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Arum Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Arum Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeoul

Year Founded2019

Last FundingApr 19, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.